Literature DB >> 17005346

Epilepsy surgery in a patient with Lennox-Gastaut syndrome and cortical dysplasia.

Su Jeong You1, Jung-Kyo Lee, Tae-Sung Ko.   

Abstract

Lennox-Gastaut syndrome (LGS) is classified as a generalized epilepsy, and is often intractable to antiepileptic drugs. Although corpus callosotomy may sometimes control drop attacks, curative epilepsy surgery is rarely possible in LGS. We report, here, a patient with LGS and focal cortical dysplasia, who became seizure-free after epilepsy surgery. The patient was a 24-month-old boy without perinatal insult in whom seizures began 7 days after birth and who experienced development delay. Brain magnetic resonance imaging (MRI) showed focal cortical lesion with calcification in the right frontal area. At age 13 months, his seizure type changed from tonic seizures to head drops (atonic types) and atypical absence seizures. His interictal electroencephalogram (EEG) showed generalized slow spike and wave discharges, and he was diagnosed with LGS. His seizures were intractable to medical treatment, and a ketogenic diet was not effective. He was evaluated prior to surgery by long-term video-EEG monitoring, which detected many seizures consisted of a sudden onset of falling attacks (atonic type) intermittently followed by atypical absence seizures with diffuse slow wave bursts followed by slow spike and wave discharges in ictal EEG, brain positron emission tomography (PET) and MRI. A right frontal lesionectomy with intra-operative electrocorticography (EcoG) was performed. From the time of lesionectomy to the present, the patient has been seizure free and has been developing normally. Our results suggest that focal resective surgery should be considered in patients with LGS and focal epileptic lesions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17005346     DOI: 10.1016/j.braindev.2006.07.013

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  8 in total

1.  Focal cortical dysplasia with calcification: a case report.

Authors:  Kazuhiro Samura; Takato Morioka; Fumiaki Yoshida; Kimiaki Hashiguchi; Yasushi Miyagi; Masahiro Mizoguchi; Tadahisa Shono; Shinji Nagata; Satoshi O Suzuki; Tomio Sasaki
Journal:  Childs Nerv Syst       Date:  2007-12-22       Impact factor: 1.475

2.  Targeting the Mammalian Target of Rapamycin for Epileptic Encephalopathies and Malformations of Cortical Development.

Authors:  Anna Jeong; Michael Wong
Journal:  J Child Neurol       Date:  2017-03-16       Impact factor: 1.987

3.  Clobazam as an adjunctive therapy in treating seizures associated with Lennox-Gastaut syndrome.

Authors:  Jennifer T Leahy; Catherine J Chu-Shore; Janet L Fisher
Journal:  Neuropsychiatr Dis Treat       Date:  2011-11-11       Impact factor: 2.570

4.  Surgical treatment of patients with Lennox-Gastaut syndrome phenotype.

Authors:  Shi-Yong Liu; Ning An; Xiang Fang; Prabhdeep Singh; Joseph Oommen; Qing Yin; Mei-Hua Yang; Yong Liu; Wei Liao; Chang-Qing Gao; Hui Yang
Journal:  ScientificWorldJournal       Date:  2012-05-01

Review 5.  Conceptualizing lennox-gastaut syndrome as a secondary network epilepsy.

Authors:  John S Archer; Aaron E L Warren; Graeme D Jackson; David F Abbott
Journal:  Front Neurol       Date:  2014-10-30       Impact factor: 4.003

Review 6.  Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions.

Authors:  Adam P Ostendorf; Yu-Tze Ng
Journal:  Neuropsychiatr Dis Treat       Date:  2017-04-20       Impact factor: 2.570

7.  Treatment of Lennox-Gastaut syndrome: overview and recent findings.

Authors:  Kenou van Rijckevorsel
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

8.  Staged total callosotomy for lennox-gastaut syndrome: a case report.

Authors:  Eun Hye Lee; Mi-Sun Yum; Seok-Ho Hong; Jeong-Kyo Lee; Su Jeong You; Tae-Sung Ko
Journal:  J Epilepsy Res       Date:  2011-12-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.